Stem Cell Research
Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)
Published in Cancer Weekly, December 8th, 2009
Biopharmaceutical company Kiadis Pharma announces that the first patients have been enrolled in its multinational registration clinical trial with ATIR™. The study is designed to show reduction in transplant related mortality (TRM) after one year following an allogeneic stem cell transplantation with a mismatched (haplo-identical) donor in blood cancer patients eligible for an allogeneic stem cell transplantation but without having a matched donor available.
The study is currently open for enrollment in centers in Europe and Canada and is designed to serve as a registration trial for European approval.
"We are very pleased to initiate the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-12-08)
More Articles from Cancer Weekly
- American College of Radiology / American Roentgen Ray Society
Radiology procedure may help increase long-term survival in patients with severe liver cancer - American Society for Radiation Oncology
Rare pancreatic cancer patients may live longer when treated with radiation therapy - Institute for Quality and Efficiency in Health Care
In Germany, children with cancer have a high probability of survival - Journal of the National Cancer Institute
Funeral industry workers exposed to formaldehyde face higher risk of leukemia - Journal of the National Cancer Institute
Promoting healthy skepticism in the news: Helping journalists get it right - Texas A&M AgriLife Communications
New imagining technique could lead to better antibiotics and cancer drugs - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
